Together, these data suggest that in carriers of the PROCR-219Gly genotype, who exhibit elevated APC levels (as measured on the SomaScan platform), the lower genetic susceptibility to arterial disease may be due to a reduced number of leukocyte–endothelial cell adhesion events at sites of vascular inflammation. Here, APC is linked to arterial disorder.